The Growing PD-1 and PD-L1 Inhibitor Market Driven by Rising Cancer Incidence The global PD-1 and PD-L1 Inhibitor market overview comprises immune checkpoint inhibitors targeting the programmed death 1 (PD-1) receptor and its ligands, programmed death ligand 1 (PD-L1). These drugs work by blocking the interaction between PD-1 and PD-L1/PD-L2, which enables tumor cells to evade immune responses. PD-1 and PD-L1 inhibitors have revolutionized cancer treatment and are now...
0 Compartilhamentos
359 Visualizações